MX2017009714A - Method for producing pyrazine carboxamide compound, and synthetic intermediate thereof. - Google Patents
Method for producing pyrazine carboxamide compound, and synthetic intermediate thereof.Info
- Publication number
- MX2017009714A MX2017009714A MX2017009714A MX2017009714A MX2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A MX 2017009714 A MX2017009714 A MX 2017009714A
- Authority
- MX
- Mexico
- Prior art keywords
- carboxamide compound
- synthetic intermediate
- pyrazine carboxamide
- production
- producing
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 5
- 229960005206 pyrazinamide Drugs 0.000 title abstract 4
- -1 pyrazine carboxamide compound Chemical class 0.000 title abstract 4
- 239000000463 material Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 229940127557 pharmaceutical product Drugs 0.000 abstract 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000010898 silica gel chromatography Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
[Problem] To provide: a novel method for producing a pyrazine carboxamide compound as a production material of pharmaceutical products, etc.; and a synthetic intermediate that is useful in said production method. [Solution] As a result of diligent research on production methods in industrially producing a pyrazine carboxamide compound, the inventors have found that, by using a predetermined material and synthetic intermediate, a pyrazine carboxamide compound can be produced according to a method that is suitable for industrial production as a pharmaceutical product, does not require purification by silica gel column chromatography, and in which overall yield is greatly improved, thus accomplishing the present invention.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015014533 | 2015-01-28 | ||
| PCT/JP2016/052229 WO2016121777A1 (en) | 2015-01-28 | 2016-01-27 | Method for producing pyrazine carboxamide compound, and synthetic intermediate thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017009714A true MX2017009714A (en) | 2017-11-17 |
Family
ID=56543388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017009714A MX2017009714A (en) | 2015-01-28 | 2016-01-27 | Method for producing pyrazine carboxamide compound, and synthetic intermediate thereof. |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPWO2016121777A1 (en) |
| KR (1) | KR20170105021A (en) |
| CN (1) | CN107207468A (en) |
| CA (1) | CA2975072A1 (en) |
| MX (1) | MX2017009714A (en) |
| WO (1) | WO2016121777A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2018079570A1 (en) * | 2016-10-26 | 2019-09-19 | アステラス製薬株式会社 | Stable pharmaceutical composition |
| US20230167099A1 (en) * | 2020-06-01 | 2023-06-01 | Wigen Biomedicine Technology (shanghai) Co., Ltd. | New pyrazine compound |
| IL313670A (en) | 2021-12-30 | 2024-08-01 | Biomea Fusion Inc | Pyrazine compounds as inhibitors of flt3 |
| AU2023294689A1 (en) * | 2022-06-14 | 2025-01-30 | Principia Biopharma Inc. | Methods of making tolebrutinib |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5754177A (en) * | 1980-09-19 | 1982-03-31 | Teikoku Hormone Mfg Co Ltd | CHIKANCHIAZOORUJUDOTAI |
| JP3534903B2 (en) * | 1995-06-09 | 2004-06-07 | 鐘淵化学工業株式会社 | Method for producing 1- [3-chloro- (2S) -methylpropionyl] -pyrrolidine- (2S) -carboxylic acid |
| UA111010C2 (en) * | 2012-01-17 | 2016-03-10 | Астеллас Фарма Інк. | PIRASINCARBOXAMID COMPOUND |
-
2016
- 2016-01-27 WO PCT/JP2016/052229 patent/WO2016121777A1/en not_active Ceased
- 2016-01-27 KR KR1020177020729A patent/KR20170105021A/en not_active Withdrawn
- 2016-01-27 JP JP2016572078A patent/JPWO2016121777A1/en active Pending
- 2016-01-27 CA CA2975072A patent/CA2975072A1/en not_active Abandoned
- 2016-01-27 CN CN201680007743.9A patent/CN107207468A/en active Pending
- 2016-01-27 MX MX2017009714A patent/MX2017009714A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2016121777A1 (en) | 2017-11-02 |
| CA2975072A1 (en) | 2016-08-04 |
| WO2016121777A1 (en) | 2016-08-04 |
| KR20170105021A (en) | 2017-09-18 |
| CN107207468A (en) | 2017-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017009714A (en) | Method for producing pyrazine carboxamide compound, and synthetic intermediate thereof. | |
| MY160954A (en) | Agomelatine intermediates and preparation method thereof | |
| MX2016012851A (en) | A method to produce 1,1,2,3-tetrachloropropene with high yield. | |
| WO2015188243A9 (en) | PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM | |
| FR2986000B1 (en) | PROCESS FOR THE PRODUCTION OF 2-OCTYL ACRYLATE BY TRANSESTERIFICATION | |
| CN106146363A (en) | The synthetic method of medical material 3-methyl sulfinic acid amine salt | |
| CN106117210A (en) | The synthetic method of medicine intermediate hydroxyl 3-hydroxypyrrole pyrimidine | |
| CN105753771A (en) | A synthetic method of a medical intermediate trans-3-N-boc-aminopiperidine | |
| CN106117209A (en) | The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-4-pyrrolopyrimidine | |
| CN106117105A (en) | The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-3-hydroxyethyl-pyrrolidone | |
| CN106117107A (en) | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-4-methyl pyrrolidone | |
| CN106117106A (en) | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-ethyl pyrrolidone | |
| CN106117102A (en) | The synthetic method of medicine intermediate trans 3-t-butoxycarbonyl amino pyrrolidine | |
| CN106146376A (en) | The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone | |
| CN106117149A (en) | The synthetic method of medicine intermediate 1,3-bis-chloro-5-trifluoromethyl pyrimidine | |
| CN106117103A (en) | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-(methoxymethyl-carbamyl) pyrrolidine | |
| CN106117136A (en) | The synthetic method of medical material 1,3-difluoro pyridine | |
| CN106117124A (en) | The synthetic method of medical material 3-bromo-5-fluorine pyridine | |
| CN106117208A (en) | The synthetic method of medicine intermediate 5-ethoxy pyrrolopyrimidine | |
| CN106117127A (en) | The synthetic method of medical material 1,4-dibromo pyridine | |
| CN106146499A (en) | The synthetic method of medicine intermediate 5-trifluoroethyl guanine | |
| CN106117126A (en) | The synthetic method of medical material 2-bromo-4-fluorine pyridine | |
| CN106496134A (en) | The synthetic method of 5 fluorine of medical raw material, 2 methyl, 4 pyrimidinamine | |
| CN106117108A (en) | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-methylpyrrole piperidines | |
| CN105753773A (en) | A synthetic method of a medicine raw material 2-chloro-4-fluoropyridine |